80 results
424B3
KZIA
Kazia Therapeutics Limited
23 May 24
Prospectus supplement
7:03am
similar words. Any statement describing Kazia’s future plans, strategies, intentions, expectations, objectives, goals or prospects, and other
6-K
KZIA
Kazia Therapeutics Limited
23 May 24
Current report (foreign)
7:00am
statement describing Kazia’s future plans, strategies, intentions, expectations, objectives, goals or prospects, and other statements
424B3
KZIA
Kazia Therapeutics Limited
1 May 24
Prospectus supplement
4:06pm
, strategies, intentions, expectations, objectives, goals or prospects, and other statements that are not historical facts, are also forward-looking
6-K
EX-99.1
KZIA
Kazia Therapeutics Limited
1 May 24
Kazia Reports Successful Stage 1 Completion of the EVT801
4:01pm
, intentions, expectations, objectives, goals or prospects, and other statements that are not historical facts, are also forward-looking statements, including
424B3
KZIA
Kazia Therapeutics Limited
27 Mar 24
Prospectus supplement
8:37am
describing Kazia’s future plans, strategies, intentions, expectations, objectives, goals or prospects, and other statements that are not historical
6-K
EX-99.1
wcvjazgebdl
26 Mar 24
Current report (foreign)
8:02am
424B3
ccc5c6
21 Feb 24
Prospectus supplement
4:19pm
6-K
EX-99.1
pv5gskmrbficdil
21 Feb 24
Kazia Therapeutics Reports Early Conclusion of Clinical Trial After Reaching Primary Endpoint
9:19am
6-K
EX-99.1
l2m1m347y 2kp2pe91
18 Jan 24
Current report (foreign)
4:30pm
6-K
EX-99.1
xz7 mtqjq9k4ia8meoj
6 Dec 23
Kazia Therapeutics Announces Closing of $2 Million Registered Direct Offering
8:31am
6-K
EX-99.1
nlvqr1vkp411n cb
1 Dec 23
Kazia Therapeutics Announces $2 Million Registered Direct Offering
8:30am
6-K
EX-99.1
1jvrf1dztalmcz8vw
29 Nov 23
Kazia Announces Non-binding Letter of
4:19pm
6-K
EX-99.1
cvpe5 qr1n4
21 Nov 23
Current report (foreign)
4:09pm
6-K
EX-99.1
rjz5zh5rh1td
20 Nov 23
Kazia Announces Receipt of Nasdaq Minimum Bid Notification
4:39pm
6-K
EX-99.1
uuymhit2q6trzcpmdnjw
15 Nov 23
Kazia Announces the Release of PNOC022
9:13am
6-K
EX-99.1
sd1qt2
14 Nov 23
Kazia Announces Publication In Molecular
12:00am
6-K
EX-99.1
pi5ft
1 Nov 23
Kazia Therapeutics Provides Preliminary Update
4:17pm
6-K
EX-99.1
ktmy2ant
23 Oct 23
Kazia Therapeutics Announces Clinical Data at Esmo 2023 from Ongoing Phase 1 EVT801 Study
8:30am
6-K
EX-99.1
ki4h6n8vem9x4n
13 Oct 23
Current report (foreign)
4:08pm